Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A7 | Q99884 | 1/20 | 0.55 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.52 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.48 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4423901 | 0.90 | ALDH1A1 (0.61) | ALDH1A1CDK5CDK5R1 | |
| SCHEMBL4419055 | 0.88 | SLC6A7 (0.58) | SLC6A7 | |
| SCHEMBL4420180 | 0.88 | SLC6A7 (0.58) | SLC6A7ALDH1A1 | |
| SCHEMBL4426562 | 0.85 | ALDH1A1 (0.54) | SLC6A7ALDH1A1CDK5CDK5R1 | |
| SCHEMBL4429068 | 0.82 | HPGD (0.50) | TLR8TLR7 | |
| SCHEMBL4419121 | 0.82 | TLR8 (0.50) | SLC6A7TLR8TLR7ALDH1A1 | |
| SCHEMBL4415929 | 0.82 | TLR8 (0.49) | SLC6A7TLR8TLR7 | |
| SCHEMBL4430450 | 0.82 | TLR8 (0.49) | TLR8TLR7ALDH1A1 | |
| SCHEMBL4418456 | 0.80 | NAMPT (0.49) | SLC6A7TLR8TLR7 | |
| SCHEMBL4413770 | 0.79 | TLR8 (0.49) | SLC6A7TLR8TLR7ALDH1A1CDK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090325964-A1 | Piperazine Metabotropic Glutamate Receptor 5 (MGLUR5) Negative Allosteric Modulators For Anxiety/Depression | WYETH (US) | 2009-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090325964-A1 | Piperazine Metabotropic Glutamate Receptor 5 (MGLUR5) Negative Allosteric Modulators For Anxiety/Depression | GRM5, GRIK5, GRM1 | SLC6A7 234/4885TLR8 995/4885TLR7 207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.